Pathogen-reduced platelets for the prevention of bleeding-Reference-Cited by-同舟云学术

Pathogen-reduced platelets for the prevention of bleeding

Published:2017-07-30 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Estcourt Lise J¹,Malouf Reem²,Hopewell Sally³,Trivella Marialena⁴,Doree Carolyn⁵,Stanworth Simon J⁶,Murphy Michael F⁷

Affiliation:

1. NHS Blood and Transplant; Haematology/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ

2. University of Oxford; National Perinatal Epidemiology Unit (NPEU); Old Road Campus Oxford UK OX3 7LF

3. University of Oxford; Oxford Clinical Trials Research Unit; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences Windmill Road Oxford Oxfordshire UK OX3 7LD

4. University of Oxford; Centre for Statistics in Medicine; Botnar Research Centre Windmill Road Oxford UK OX3 7LD

5. NHS Blood and Transplant; Systematic Review Initiative; John Radcliffe Hospital Oxford UK OX3 9BQ

6. Oxford University Hospitals NHS Foundation Trust and University of Oxford; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; John Radcliffe Hospital, Headley Way Headington Oxford UK OX3 9BQ

7. Oxford University Hospitals NHS Foundation Trust and University of Oxford; NHS Blood and Transplant; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; John Radcliffe Hospital Headington Oxford UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference143 articles.

1. Clinical study in pediatric hemato-oncology patients: efficacy of pathogen inactivated buffy coat platelets versus aphaeresis platelets;Agliastro;Transfusion,2006

2. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates;Ambruso;Transfusion,2009

3. Clinical evaluation of Mirasol PRT treated apheresis platelets in thrombocytopenic patients;Goodrich;Transfusion,2008

4. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology;Mirasol Clinical Evaluation Study Group;Transfusion,2010

5. NCT00263809 Safety and performance of MIRASOL® PRT treated platelet transfusion products clinicaltrials.gov/ct2/show/NCT00263809

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neonatal Blood Banking Practices;Clinics in Perinatology;2023-12

2. Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies;Pathogens;2023-07-05

3. A multidisciplinary comparison of transfusion and perioperative support for high‐risk cardiac surgery at three large academic centres in North America;Transfusion Medicine;2023-05-12

4. Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review;Vox Sanguinis;2022-12

5. INTERCEPT Pathogen Reduction in Platelet Concentrates, in Contrast to Gamma Irradiation, Induces the Formation of trans-Arachidonic Acids and Affects Eicosanoid Release during Storage;Biomolecules;2022-09-07